Richard Dillon

InstitutionHaematology Department
AddressLondon
United Kingdom
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 4 Covid-19 publications, with a maximum of 1 publications in July 2020 and March 2021 and May 2021 and June 2021
    All Publications
    Bar chart showing 18 publications over 12 distinct years, with a maximum of 4 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Harrington P, Doores KJ, Radia D, O'Reilly A, Lam HPJ, Seow J, Graham C, Lechmere T, McLornan D, Dillon R, Shanmugharaj Y, Espehana A, Woodley C, Saunders J, Curto-Garcia N, O'Sullivan J, Raj K, Kordasti S, Malim MH, Harrison C, de Lavallade H. Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces neutralising antibody and polyfunctional T-cell responses in patients with chronic myeloid leukaemia. Br J Haematol. 2021 09; 194(6):999-1006. PMID: 34085278.
      Citations: 6     Fields:    Translation:HumansCellsCTClinical Trials
    2. Harrington P, de Lavallade H, Doores KJ, O'Reilly A, Seow J, Graham C, Lechmere T, Radia D, Dillon R, Shanmugharaj Y, Espehana A, Woodley C, Saunders J, Curto-Garcia N, O'Sullivan J, Raj K, Kordasti S, Malim MH, Harrison CN, McLornan DP. Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms. Leukemia. 2021 12; 35(12):3573-3577. PMID: 34023850.
      Citations: 8     Fields:    Translation:HumansCells
    3. Harrington P, Harrison CN, Dillon R, Radia DH, Rezvani K, Raj K, Woodley C, Curto-Garcia N, O'Sullivan J, Saunders J, Kordasti S, Ali S, de Lavallade H, McLornan DP. Evidence of robust memory T-cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Br J Haematol. 2021 05; 193(4):692-696. PMID: 33719038.
      Citations: 4     Fields:    Translation:HumansCells
    4. Russell B, Moss C, Papa S, Irshad S, Ross P, Spicer J, Kordasti S, Crawley D, Wylie H, Cahill F, Haire A, Zaki K, Rahman F, Sita-Lumsden A, Josephs D, Enting D, Lei M, Ghosh S, Harrison C, Swampillai A, Sawyer E, D'Souza A, Gomberg S, Fields P, Wrench D, Raj K, Gleeson M, Bailey K, Dillon R, Streetly M, Rigg A, Sullivan R, Dolly S, Van Hemelrijck M. Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London. Front Oncol. 2020; 10:1279. PMID: 32903324.
      Citations: 18     
    5. Milne P, Wilhelm-Benartzi C, Grunwald MR, Bigley V, Dillon R, Freeman SD, Gallagher K, Publicover A, Pagan S, Marr H, Jones GL, Dickinson AM, Grech A, Burnett AK, Russell NH, Levis M, Knapper S, Collin M. Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia. Blood Adv. 2019 10 22; 3(20):3052-3061. PMID: 31648336.
      Citations: 4     Fields:    Translation:HumansCells
    6. Lofaro T, Saha A, Raj K, Dillon R. Non-malignant CSF lymphocytosis in a patient with acute lymphoblastic leukemia. IDCases. 2018; 14:e00447. PMID: 30202728.
      Citations:    
    7. Russell N, Burnett A, Hills R, Betteridge S, Dennis M, Jovanovic J, Dillon R, Grimwade D. Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial. Blood. 2018 09 27; 132(13):1452-1454. PMID: 30097508.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    8. Buccisano F, Dillon R, Freeman SD, Venditti A. Role of Minimal (Measurable) Residual Disease Assessment in Older Patients with Acute Myeloid Leukemia. Cancers (Basel). 2018 Jun 26; 10(7). PMID: 29949858.
      Citations: 8     
    9. Freeman SD, Hills RK, Virgo P, Khan N, Couzens S, Dillon R, Gilkes A, Upton L, Nielsen OJ, Cavenagh JD, Jones G, Khwaja A, Cahalin P, Thomas I, Grimwade D, Burnett AK, Russell NH. Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations. J Clin Oncol. 2018 05 20; 36(15):1486-1497. PMID: 29601212.
      Citations: 35     Fields:    Translation:Humans
    10. Dillon R, Grimwade D. Just 1 test to diagnose AML?!! Blood. 2016 07 07; 128(1):8-10. PMID: 27389539.
      Citations:    Fields:    Translation:Humans
    11. Li S, Garrett-Bakelman FE, Chung SS, Sanders MA, Hricik T, Rapaport F, Patel J, Dillon R, Vijay P, Brown AL, Perl AE, Cannon J, Bullinger L, Luger S, Becker M, Lewis ID, To LB, Delwel R, Löwenberg B, Döhner H, Döhner K, Guzman ML, Hassane DC, Roboz GJ, Grimwade D, Valk PJ, D'Andrea RJ, Carroll M, Park CY, Neuberg D, Levine R, Melnick AM, Mason CE. Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia. Nat Med. 2016 07; 22(7):792-9. PMID: 27322744.
      Citations: 122     Fields:    Translation:HumansCells
    12. Kühnl A, Valk PJ, Sanders MA, Ivey A, Hills RK, Mills KI, Gale RE, Kaiser MF, Dillon R, Joannides M, Gilkes A, Haferlach T, Schnittger S, Duprez E, Linch DC, Delwel R, Löwenberg B, Baldus CD, Solomon E, Burnett AK, Grimwade D. Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia. Blood. 2015 May 07; 125(19):2985-94. PMID: 25805812.
      Citations: 24     Fields:    Translation:HumansCells
    13. Dillon R, Grimwade D. Prognostic significance of additional cytogenetic abnormalities and FLT3 mutations in acute promyelocytic leukemia. Leuk Lymphoma. 2014 Jul; 55(7):1444-6. PMID: 24313832.
      Citations: 2     Fields:    Translation:Humans
    14. Radia D, Momoh I, Dillon R, Francis Y, Cameron L, Fagg TL, Overland H, Robinson S, Harrison CN. Anemia management: development of a rapidaccess anemia and intravenous iron service. Risk Manag Healthc Policy. 2013; 6:13-22. PMID: 23950666.
      Citations: 3     
    15. Dillon R, Momoh I, Francis Y, Cameron L, Harrison CN, Radia D. Comparative efficacy of three forms of parenteral iron. J Blood Transfus. 2012; 2012:473514. PMID: 24089648.
      Citations: 6     
    16. Dillon R, O'Connell S, Wright S. Lyme disease in the U.K.: clinical and laboratory features and response to treatment. Clin Med (Lond). 2010 Oct; 10(5):454-7. PMID: 21117376.
      Citations: 2     Fields:    Translation:Humans
    17. Dillon R, Harrison C. Full blood count. Br J Hosp Med (Lond). 2009 Mar; 70(3):M38-41. PMID: 19274019.
      Citations: 1     Fields:    Translation:Humans
    18. Dillon R, Hirschfield GM, Allison ME, Rege KP. Fatal reactivation of hepatitis B after chemotherapy for lymphoma. BMJ. 2008 Jul 01; 337:a423. PMID: 18595895.
      Citations: 6     Fields:    Translation:HumansCells